TEVA PHARMACEUTICAL INDUSTRIES LIMITED Long-Term Debt, Maturity, Year Five
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Long-Term Debt, Maturity, Year Five of $3.73 billion as of 2020-12-31, per its 10-K filed 2021-02-10.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2021-02-10
- 2020-12-31: Long-Term Debt, Maturity, Year Five $3.73B.
- 2017-12-31: Long-Term Debt, Maturity, Year Five $1.74B.
- 2016-12-31: Long-Term Debt, Maturity, Year Five $4.21B.
- 2015-12-31: Long-Term Debt, Maturity, Year Five $700.00M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2020-12-31 | $3.73B 10-K · filed 2021-02-10 |
| 2017-12-31 | $1.74B 10-K · filed 2018-02-12 |
| 2016-12-31 | $4.21B 20-F · filed 2017-02-15 |
| 2015-12-31 | $700.00M 20-F · filed 2016-02-11 |
| 2014-12-31 | $1.52B 20-F · filed 2015-02-09 |
| 2013-12-31 | $875.00M 20-F · filed 2014-02-10 |
| 2012-12-31 | $792.00M 20-F · filed 2013-02-12 |
| 2011-12-31 | $1.50B 20-F · filed 2012-02-17 |
| 2010-12-31 | $1.48B 20-F · filed 2011-02-15 |